<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04791501</url>
  </required_header>
  <id_info>
    <org_study_id>PI201935</org_study_id>
    <nct_id>NCT04791501</nct_id>
  </id_info>
  <brief_title>Prevalence AND Outcome of Acute Hypoxemic Respiratory fAilure in CHILDren (PANDORA-CHILD)</brief_title>
  <acronym>PANDORA-child</acronym>
  <official_title>Prevalence and Outcome of Acute Hypoxemic Respiratory Failure in Children.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yolanda Lopez Fernandez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Infantil Universitario Niño Jesús, Madrid, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Consorcio Centro de Investigación Biomédica en Red, M.P.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. Negrin University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital de Cruces</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study is aimed to establish the epidemiological characteristics and clinical&#xD;
      outcomes of mechanically ventilated children with acute hypoxemic respiratory failure (AHRF),&#xD;
      defined as PaO2/FiO2 ≤300 mmHg on PEEP≥5 cmH2O and FiO2≥0.3, admitted in a network of&#xD;
      pediatric hospitals in Spain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, multicenter, observational study focused on the prevalence and outcomes of Acute&#xD;
      Hypoxemic Respiratory Failure in children. From a total of 40 pediatric ICUs in Spain, 22&#xD;
      PICUs agreed to participate.&#xD;
&#xD;
      All consecutive patients from 7 days to 16 years old admitted in the PICU will have been&#xD;
      enrolled if they fulfilled the following criteria: 1) acute episode (within 7 days of a&#xD;
      clinical insult), 2) on invasive mechanical ventilatory support, 3) PaO2/FiO2 ≤ 300 mmHg (or&#xD;
      SpO2/FiO2 ≤ 264), 4) Positive end-expiratory pressure (PEEP) ≥ 5 cmH2O and FiO2 ≥ 0.3.&#xD;
&#xD;
      This study is considered an audit, and informed consent is waived.&#xD;
&#xD;
      Period of study: 2 years (October 2019 to September 2021). Recruitment period: two&#xD;
      consecutive months (i.e October-November followed by a period of no recruitment) until&#xD;
      complete 12 months of recruitment (September 2021).&#xD;
&#xD;
      All investigators have received guidelines outlining the study design and the methods for&#xD;
      data collection. All PICU admissions are screened daily for AHRF. Onset of AHRF was defined&#xD;
      as the day on which the patient first met all inclusion criteria. All data are collected on&#xD;
      standardized forms. Demographics, comorbidities, reason for initiation of IMV, arterial blood&#xD;
      gases, laboratory, radiographic, hemodynamic and ventilator data were collected at study&#xD;
      entry and during the first three days of AHRF diagnosis (T0 or time of inclusion in the&#xD;
      study, 24 hours, days 2 and 3). Chest imaging (chest radiographs, lung ultrasound or computed&#xD;
      tomography) were evaluated daily for the presence or absence of infiltrates, atelectasis,&#xD;
      acute pulmonary edema, pleural effusion or pneumothorax. Tidal volume (VT) was calculated on&#xD;
      the basis of the predicted body weight (PBW). Plateau pressure (Pplat) was determined after&#xD;
      the application of a 0.5- to 1.0-sec end-inspiratory hold. Driving pressure was calculated as&#xD;
      the difference between Pplat and PEEP. Patients meeting pediatric ARDS criteria were&#xD;
      stratified into a mild, moderate, and severe according to PALICC definition and/or berlin&#xD;
      definition. All patients are followed until PICU and hospital discharge.&#xD;
&#xD;
      Data are initially collected and stored at each center and then sent to study coordinators at&#xD;
      the time of patient's hospital discharge.&#xD;
&#xD;
      Although patient care is not strictly protocolized, physicians are asked to follow the&#xD;
      current standards of pediatric critical care management. For ventilatory management, it was&#xD;
      recommended that all patients be ventilated with a VT of 6-8 mL/kg PBW, at a ventilatory rate&#xD;
      to maintain PaCO2 at 35-50 mm Hg, a Pplat &lt;30 cm H2O, and PEEP and FiO2 combinations to&#xD;
      maintain PaO2 &gt;60 mm Hg or SpO2 &gt;90%.&#xD;
&#xD;
      Statistical Analysis: for the main objective of the study, a descriptive analysis including&#xD;
      clinical variables, mechanical ventilation data, respiratory settings and ancillary measures&#xD;
      will be performed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">October 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of hypoxemic acute respiratory failure.</measure>
    <time_frame>12 months</time_frame>
    <description>The investigators will calculate the prevalence in relation to: (i) total number of ICU admissions during the study period in all participating centers; (ii) total number of mechanically ventilated patients during the study period in all participating centers, and (iii) per ICU bed available in the participating centers over the study period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death in the ICU and in the hospital</measure>
    <time_frame>through study completion, an average of 60 days</time_frame>
    <description>Outcome after discharge from ICU and before discharge to home (overall and in each category of acute hypoxemic respiratory failure).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Acute Respiratory Insufficiency</condition>
  <arm_group>
    <arm_group_label>Hypoxemic Respiratory Failure</arm_group_label>
    <description>Consecutive intubated patients receiving invasive mechanical ventilation with a PaO2/FiO2 ≤300 mmHg under a PEEP of 5 cmH2O or more and FiO2 of 0.3 or more.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mechanical ventilation</intervention_name>
    <description>Ventilatory support</description>
    <arm_group_label>Hypoxemic Respiratory Failure</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients from 7 days to 16 years old admitted in the PICU with an acute&#xD;
        episode (within 7 days of a clinical insult) of hipoxemia defined as PaO2/FiO2 ≤ 300 mmHg&#xD;
        (or SpO2/FiO2 ≤ 264), and on invasive mechaniccal ventilatio with a PEEP ≥ 5 cmH2O and FiO2&#xD;
        ≥ 0.3.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients from 7 days to 16 years old admitted in the PICU.&#xD;
&#xD;
          -  Acute episode (within 7 days of a clinical insult)&#xD;
&#xD;
          -  On invasive mechanical ventilatory support&#xD;
&#xD;
          -  PaO2/FiO2 ≤ 300 mmHg (or SpO2/FiO2 ≤ 264)&#xD;
&#xD;
          -  Positive end-expiratory pressure (PEEP) ≥ 5 cmH2O and FiO2 ≥ 0.3.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-invasive respiratory support *Aged &gt;16 years or &lt; 7 days.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jesús Villar Hernández, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Multidisciplinary Organ Dysfunction Evaluation Research Network (MODERN). Research Unit, hospital universitario dr. negrín, Las Palmas de gran Canaria, Spain.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yolanda M López-Fernández, MD</last_name>
    <phone>0034946006000</phone>
    <phone_ext>6582</phone_ext>
    <email>yolandamarg.lopezfernandez@osakidetza.eus</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amelia Martinez de Azagra, MD</last_name>
    <phone>0034630122450</phone>
    <email>ameliamartinezdeazgra@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cruces University Hospital</name>
      <address>
        <city>Barakaldo</city>
        <state>Bizkaia</state>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yolanda M López-Fernández, MD</last_name>
      <phone>0034946000000</phone>
      <phone_ext>6582</phone_ext>
      <email>yolandamarg.lopezfernandez@osakidetza.eus</email>
    </contact>
    <investigator>
      <last_name>Yolanda M Lopez Fernandez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Javier Pilar Orive, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Donosti</name>
      <address>
        <city>Donostia</city>
        <state>Gipuzkoa</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eider Oñate</last_name>
      <email>eider.oñatevergara@osakidetza.eus</email>
    </contact>
    <investigator>
      <last_name>Eider Oñate, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nerea Ovelar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario</name>
      <address>
        <city>Burgos</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María González, MD</last_name>
      <email>lapuris@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>María García, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabel del Blanco, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta del Mar</name>
      <address>
        <city>Cadiz</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Rodriguez</last_name>
      <email>p.r.campoy@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Patricia Rodriguez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorena Estepa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofia</name>
      <address>
        <city>Córdoba</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ignacio Ibarra, MD</last_name>
      <email>igibarrarosa@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ignacio Ibarra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario</name>
      <address>
        <city>Las Palmas De Gran Canaria</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rocio Nuñez, MD</last_name>
      <email>rocio.nuñez.borrero@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Rocio Nuñez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sira Alonso, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan I Sanchez, MD</last_name>
      <email>juanigancio.sanchez@madrid.salud.org</email>
    </contact>
    <investigator>
      <last_name>Juan I Sanchez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Llorente, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Herrera, MD</last_name>
      <email>laura.herreracastillo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Laura Herrera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Butragueño, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Gomez Zamora, MD</last_name>
      <email>agzamora77@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ana Gomez Zamora, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pedro de la Oliva, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Coca, MD</last_name>
      <email>pdacoca@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ana Coca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cesar Perez-Caballero, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Arrixaca</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susana B Reyes, MD, PhD</last_name>
      <email>susanareyes.3110@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Susana B Reyes, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>María Miñambres, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Niño Jesús University Hospital</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amelia Martínez de Azagra, MD</last_name>
      <email>ameliamartinezdeazagra@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Amelia Martinez de Azagra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angeles Garcia Teresa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose M Gonzalez</last_name>
      <email>josemagogo@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Jose M Gonzalez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonio Morales, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Medina, MD, PhD</last_name>
      <email>amedinavillanueva@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Alberto Medina, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Mayordomo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Camino</name>
      <address>
        <city>Pamplona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mikel Mendizabal, MD</last_name>
      <email>mmendizabaldiez@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mikel Mendizabal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>María Amores, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Fernández, MD</last_name>
      <email>pacojum@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Francisco Fernández, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sira Fernández, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Santiago de Compostela</name>
      <address>
        <city>Santiago De Compostela</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Rodriguez, MD</last_name>
      <email>antonio.rodruiguez.nuñez@sergas.es</email>
    </contact>
    <investigator>
      <last_name>Antonio Rodriguez, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Javier Trastoy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocio</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julio Parrilla, MD</last_name>
      <email>julioparril@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Julio Parrilla, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuel Fernández, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Tenerife</name>
      <address>
        <city>Tenerife</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Perez</last_name>
      <email>luisperbae@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Luis Perez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose S Leon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Salud</name>
      <address>
        <city>Toledo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Arjona, MD</last_name>
      <email>daroja@sescam.jccm.es</email>
    </contact>
    <investigator>
      <last_name>David Arjona</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>María J Perez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vicent Modesto</last_name>
      <email>vicent.modesto@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Vicent Modesto, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Brezmes</last_name>
      <email>martabrezmes@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Marta Brezmes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorena Bermudez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Madurga, MD</last_name>
      <email>paumare@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Paula Madurga, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan P Iñiguez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>López-Fernández Y, Azagra AM, de la Oliva P, Modesto V, Sánchez JI, Parrilla J, Arroyo MJ, Reyes SB, Pons-Ódena M, López-Herce J, Fernández RL, Kacmarek RM, Villar J; Pediatric Acute Lung Injury Epidemiology and Natural History (PED-ALIEN) Network. Pediatric Acute Lung Injury Epidemiology and Natural History study: Incidence and outcome of the acute respiratory distress syndrome in children. Crit Care Med. 2012 Dec;40(12):3238-45. doi: 10.1097/CCM.0b013e318260caa3.</citation>
    <PMID>22990455</PMID>
  </reference>
  <reference>
    <citation>Villar J, Blanco J, Añón JM, Santos-Bouza A, Blanch L, Ambrós A, Gandía F, Carriedo D, Mosteiro F, Basaldúa S, Fernández RL, Kacmarek RM; ALIEN Network. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011 Dec;37(12):1932-41. doi: 10.1007/s00134-011-2380-4. Epub 2011 Oct 14. Erratum in: Intensive Care Med. 2011 Dec;37(12):1942.</citation>
    <PMID>21997128</PMID>
  </reference>
  <reference>
    <citation>Kopczynska M, Sharif B, Pugh R, Otahal I, Havalda P, Groblewski W, Lynch C, George D, Sutherland J, Pandey M, Jones P, Murdoch M, Hatalyak A, Jones R, Kacmarek RM, Villar J, Szakmany T, On Behalf Of The Pandora-Wales Investigators. Prevalence and Outcomes of Acute Hypoxaemic Respiratory Failure in Wales: The PANDORA-WALES Study. J Clin Med. 2020 Oct 31;9(11). pii: E3521. doi: 10.3390/jcm9113521.</citation>
    <PMID>33142837</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 2, 2021</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2021</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Cruces</investigator_affiliation>
    <investigator_full_name>Yolanda Lopez Fernandez</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>respiratory failure</keyword>
  <keyword>mechanical ventilation</keyword>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

